San Francisco Business Times |
FDA approves HBV vaccine Heplisav-B for adults
Healio Dynavax announced that the FDA approved Heplisav-B, a recombinant hepatitis B vaccine, for all known subtypes of HBV in adults aged 18 years or older, according to a press release. William Schaffner, MD. William Schaffner. Robert Janssen, MD. FDA Approves First 2-Dose Hepatitis B Vaccine Dynavax Announces FDA Approval of First and Only Two-Dose Hepatitis B Vaccine Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up |
from Health - Google News http://ift.tt/2ztRhzR
EmoticonEmoticon